Lipocine Inc. — Form D
Lipocine Inc. of SALT LAKE CITY, X1, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-05. The offering totals $38.0M, of which $38.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-08-05
- Form: D
- Accession: 0001288320-13-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $38.0M
- Amount sold: $38.0M
- Investors: 27
- Date of first sale: 2013-07-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-200776
Issuer
- Name: Lipocine Inc.
- CIK: 0001535955
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, X1, 84108
- Phone: 801 994 7383
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| John W Higuchi | Director | Salt Lake City, UT |
| William I Higuchi | Director | Salt Lake City, UT |
| Gordhan K Patel | Director | Salt Lake City, UT |
| Mahesh V Patel | Director | Salt Lake City, UT |
| Robert K Merrell | Executive Officer | Salt Lake City, UT |
| Mahesh V Patel | Executive Officer | Salt Lake City, UT |
| Gerald K Simmons | Executive Officer | Salt Lake City, UT |
| Srinivasan K Venkateshwaran | Executive Officer | Salt Lake City, UT |
Other filings by this issuer (1)
More